Johnson Midwest Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $10.3K | Buy |
177
+1
| +0.6% | +$58 | 0.02% | 203 |
|
|
2023
Q2 | $11.2K | Buy |
176
+2
| +1% | +$128 | 0.01% | 198 |
|
|
2023
Q1 | $12.1K | Buy |
174
+1
| +0.6% | +$69 | 0.02% | 190 |
|
|
2022
Q4 | $12K | Buy |
173
+1
| +0.6% | +$69 | 0.04% | 182 |
|
|
2022
Q3 | $12 | Sell |
172
-9
| -5% | -$1 | 0.05% | 176 |
|
|
2022
Q2 | $13K | Buy |
181
+12
| +7% | +$862 | 0.02% | 162 |
|
|
2022
Q1 | $12K | Buy |
169
+1
| +0.6% | +$71 | 0.02% | 156 |
|
|
2021
Q4 | $10K | Buy |
168
+1
| +0.6% | +$60 | 0.01% | 180 |
|
|
2021
Q3 | $10K | Buy |
167
+2
| +1% | +$120 | 0.01% | 182 |
|
|
2021
Q2 | $11K | Buy |
165
+1
| +0.6% | +$67 | 0.01% | 163 |
|
|
2021
Q1 | $10K | Buy |
164
+1
| +0.6% | +$61 | 0.01% | 163 |
|
|
2020
Q4 | $10K | Buy |
+163
| New | +$10K | 0.01% | 166 |
|